nsclc
英
美
网络 非小细胞型肺癌; 非小细胞肺癌; 晚期非小细胞肺癌; 非小细胞癌; 肺癌
双语例句
- Research on Molecular Mechanism of Non-small Cell Lung Cancer ( NSCLC) Based on Bioinformatics
非小细胞肺癌发生分子机制的生物信息学研究 - OBJECTIVE: To observe the effect of Yanshu injection in combination with TP chemotherapy in the treatment of advanced non-small cell lung cancer ( NSCLC).
目的：观察岩舒注射液联合TP方案化疗治疗晚期非小细胞肺癌的临床疗效。 - Objective To evaluate the clinical significance of epidermal growth factor receptor EGFR) mutations in the treatment of non-small cell lung cancer ( NSCLC).
目的探讨外周血表皮生长因子受体（EGFR）基因突变在非小细胞肺癌（NSCLC）吉非替尼治疗适宜患者筛选中的价值。 - Objective To observe the efficacy and toxicity of gemcitabine plus Carboplatin in the treatment of advanced non-small-cell lung cancer ( NSCLC).
目的观察吉西他滨联合伯尔定治疗晚期非小细胞肺癌的疗效及毒副作用。 - Objective: To evaluate the efficacy of erlotinib on advanced NSCLC, and observe its adverse events.
目的：观察厄罗替尼治疗晚期非小细胞肺癌（NSCLC）患者的疗效和不良反应。 - Objective: To study the effect of Shenyi capsule on patients with non-small cell lung cancer ( NSCLC).
目的观察参一胶囊对非小细胞肺癌的辅助治疗作用。 - Objective To evaluate the efficacy and safety of gefitinib in the treatment of elderly patients with advanced non-small cell lung cancer ( NSCLC).
目的观察吉非替尼单药治疗对晚期非小细胞肺癌（NSCLC）老年患者的效果和安全性。 - Objective: To observe the response rate and toxicity of MVP regimen with or without photohemotherapy in the treatment of advanced non-small cell lung cancer ( NSCLC).
目的：观察MVP方案加光量子血液疗法治疗晚期非小细胞肺癌（NSCLC）的近期疗效和毒副作用。 - Objective To study differentiation of neuroendocrine ( NE) in non-small cell lung carcinoma ( NSCLC) and its effect on the responsiveness to chemotherapy.
目的为研究非小细胞肺癌的神经内分泌分化状况及其对化疗疗效的影响。 - Objective To systemically analyze the clinical value of sleeve lobectomy ( SL) and pneumonectomy ( PN) in non-small cell lung cancer ( NSCLC).
目的系统评价袖状肺叶切除与全肺切除在非小细胞肺癌治疗中临床应用价值。 - BACKGROUND& OBJECTIVE: Mediastinal lymph node staging in non-small cell lung cancer ( NSCLC) is important to choose standard treatment plan and estimating prognosis.
背景与目的：非小细胞肺癌纵隔淋巴结分期对肿瘤的规范化治疗方案的选择和预后判断具有极其重要的意义。 - Conclusion The expression of RRM1 protein in cancer tissues is closely related to the response to chemotherapy and prognosis in patients with advanced NSCLC.
结论肿瘤组织中RRM1蛋白表达与晚期NSCLC患者的化疗疗效及预后密切相关。 - Radiotherapy combined with chemotherapy is the standard therapy strategy for locally advanced unresectable non-small cell lung cancer ( NSCLC);
晚期局部不可切除非小细胞肺癌的标准治疗是联合放化疗。 - Medical oncologists are faced with multiple factors to consider when staging a patient with suspected or confirmed non-small cell lung cancer ( NSCLC).
肿瘤病学家在对可疑或确诊的非小细胞肺癌患者进行分期时要面临多方面因素的考量。 - DKK1 autoantibody may become a useful tumor marker in the diagnosis and treatment of NSCLC.
DKK-1自身抗体可能成为非小细胞肺癌诊断、治疗中一种有用的肿瘤标志物。 - Conclusions Our five-gene signature is closely associated with relapse-free and overall survival among patients with NSCLC.
结论：我们的五个基因标记与非小细胞肺癌患者的无复发及总生存率密切相关。 - The aim of this study is to evaluate the effects of erlotinib monotherapy in EGFR-mutated advanced NSCLC.
本文拟探讨厄洛替尼单药治疗EGFR突变晚期NSCLC患者的疗效。 - Combination of chemotherapy and radiotherapy is foundational treatment approach for locally advanced non-small cell lung cancer ( NSCLC) patients.
放化综合治疗是局部晚期非小细胞肺癌（NSCLC）的基本治疗策略。 - Afatinib is under development in several solid tumors including non-small cell lung cancer ( NSCLC) and head and neck cancer.
Afatinib被开发用于治疗多种实体肿瘤，包括非小细胞肺癌（NSCLC）及头颈癌。 - Conclusion: The use of TP chemotherapy combined with thermotherapy can increase effect in the treatment of advanced NSCLC.
结论：TP方案局部热疗联合可提高单纯化疗治疗中晚期非小细胞肺癌的疗效。 - Objective To compare the efficacy and side-effect of Kushen injection combined with chemotherapy and chemotherapy alone in the treatment of non-small cell lung cancer ( NSCLC).
目的观察苦参注射液加化疗与单纯化疗对晚期非小细胞肺癌的疗效及毒副反应。 - Objective To investigate the correlation between expression of CD44 in human non-small cell lung cancer ( NSCLC) and lymph node metastasis.
目的研究CD44蛋白在人非小细胞肺癌组织中的表达及其与非小细胞肺癌淋巴转移的关系。 - The differentiation of NE may be one of the factors effected the chemotherapy in NSCLC.
神经内分泌分化可能是影响NSCLC对化疗反应的重要因素之一。 - Methods The clinical data of18 patients with NSCLC and solitary brain metastasis were retrospectively analysed.
方法回顾性分析18例NSCLC单发脑转移患者的临床资料。 - Objective To explore expression of aquaporin-1 ( AQP-1) in non-small cell lung cancer and its relationship with clinical and pathological characteristics of NSCLC patients.
目的研究水通道蛋白-1（AQP-1）在非小细胞肺癌（NSCLC）组织中的表达水平及其与临床病理特征的关系。 - Observations on the treatment effect of whole-brain radiotherapy on patients of NSCLC with brain metastasis and prognostic factor;
目的观察紫杉醇、替尼泊苷及顺铂化疗同步全脑放疗治疗肺癌脑转移的临床疗效及毒副反应。 - Phase II study results of the agent ASA404 showed promise in patients with either squamous or non-squamous non-small cell lung cancer ( NSCLC).
II期临床研究结果显示ASA404药物对肺鳞状细胞癌或肺鳞状非小细胞癌（NSCLC）的治疗有效。 - We developed a five-gene signature that is closely associated with survival of patients with NSCLC.
我们发现了一个五基因标记与非小细胞肺癌的生存率有密切的关系。